4th Quarter - Report

ABBVIE, INC. for ABBVIE INC.

Firm
Client
Income
—
Expenses
$1,180,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; Columbia-America Free Trade Agreement;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

H.R. 880, American Research and Competitiveness Act of 2015; H.R. 1430, Permanent CFC Look-Through Act; S. 2260, Expiring Provisions Improvement, Reform, and Efficiency (EXPIRE) Act of 2014; H.R. 415 & S. 198, Stop Corporate Inversions Act; S. 2786, Corporate Inverters Earnings Stripping Reform; S. 2895, Pay What You Owe Before You Go Act; H.R. 1809, No Federal Contracts for Corporate Deserters Act; S. 1946, Tax Relief Extension Act of 2015; H.R. 1, Tax Reform Act of 2014; Innovation Promotion Act of 2015 (Not yet introduced); Administrations Tax Reform and 2016 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced); Senate Finance Committee Tax Reform Working Groups;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 1946 (114th), H.R. 1430 (114th), H.R. 880 (114th), S. 2786 (114th), S. 198 (114th), H.R. 1809 (114th), H.R. 415 (114th), S. 2895 (114th), S. 2260 (114th), H.R. 1 (114th)

Copyright/Patent/Trademark CPT

H.R. 3116, MODDERN Cures Act of 2013; S. 3004, Dormant Therapies Act of 2014; H.R. 406 & S. 1767, Combination Drug Development Incentive Act of 2015; H.R. 1537 & S. 1878, Advancing Hope Act of 2015; S. 1720, Patent Transparency and Improvements Act of 2013; S. 632, STRONG Patents Act of 2015; H.R. 9, Innovation Act; H.R. 160, Protect Medical Innovation Act of 2015; S. 214, Preserve Access to Affordable Generics Act of 2013; H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013; H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; Proposals/Initiatives related to international intellectual property protection;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 214 (114th), H.R. 3116 (114th), S. 1720 (114th), S. 1878 (114th), H.R. 406 (114th), H.R. 3709 (114th), S. 632 (114th), H.R. 1537 (114th), H.R. 160 (114th), S. 1767 (114th), H.R. 9 (114th), S. 1421 (114th), S. 3004 (114th), H.R. 971 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 1101 & S. 1287, Viral Hepatitis Testing Act; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act; H.R. 2228 & S.122, Safe and Affordable Drugs from Canada Act of 2015; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA); Implementation of The Biosimilars User Fee Act (BsUFA); H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; H.R. 3677 Opioid Abuse Prevention and Treatment Act of 2015;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 6 (114th), S. 122 (114th), S. 1287 (114th), S. 1396 (114th), H.R. 2570 (114th), H.R. 3677 (114th), H.R. 2228 (114th), H.R. 1101 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 2298, Medicare Patient Safety and Drug Abuse Prevention Act; H.R. 2914, Promoting Integrity in Medicare Act; H.R. 1190 & S. 141, Protecting Seniors' Access to Medicare Act of 2015; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act; H.R. 3061 & S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; H.R. 1102 & S. 117, Medicare Prescription Drug Price Negotiation Act; H.R. 2005 & S. 1083, Medicare Drug Savings Act; H. R. 3742, Access to Marketplace Insurance Act; Medicare payment proposals;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 141 (114th), S. 31 (114th), H.R. 1102 (114th), S. 117 (114th), H.R. 2914 (114th), H.R. 2925 (114th), H.R. 1190 (114th), H.R. 3742 (114th), S. 1083 (114th), H.R. 2298 (114th), H.R. 2005 (114th), H.R. 3061 (114th)

Budget/Appropriations BUD

H.R.2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act; P.L. 114-113, Consolidated Appropriations Act, 2016 (H.R. 2029); H.R. 3762, Restoring Americans' Healthcare Freedom Reconciliation Act of 2015; Other Labor, Health and Human Services Appropriations (No Bills Introduced); H.R. 1078, Food & Drug Administration Safety Over Sequestration Act; S. 1413, FDA User Fee Protection Act; FDAs Changes Being Effected Rule;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3762 (114th), H.R. 1078 (114th), H.R. 2029 (114th), S. 1413 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.